References
1. Roden DM. Drug-induced prolongation of the QT interval. N Engl
J Med . 2004;350:1013–1022.
2. Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug-Induced
QT Prolongation and Torsades de Pointes. J Am Coll Cardiol .
2016;67:1639–1650.
3. Heist E. Kevin, Ruskin Jeremy N. Drug-Induced Arrhythmia.Circulation . 2010;122:1426–1435.
4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W,
Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China
Novel Coronavirus Investigating and Research Team. A Novel Coronavirus
from Patients with Pneumonia in China, 2019. N Engl J Med .
2020;382:727–733.
5. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic
Treatments for Coronavirus Disease 2019 (COVID-19): A Review.JAMA [Internet]. 2020 [cited 2020 Apr 21];Available from:
https://jamanetwork.com/journals/jama/fullarticle/2764727
6. Roden Dan M., Harrington Robert A., Poppas Athena, Russo Andrea M.
Considerations for Drug Interactions on QTc in Exploratory COVID-19
(Coronavirus Disease 2019) Treatment. Circulation [Internet].
[cited 2020 Apr 17];0. Available from:
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047521
7. Sacher F, Fauchier L, Boveda S, de Chillou C, Defaye P, Deharo JC,
Gandjbakhch E, Probst V, Cohen A, Leclercq C, Working Group of Pacing,
Electrophysiology of the French Society of Cardiology, the Board of the
French Society of Cardiology. Use of drugs with potential cardiac effect
in the setting of SARS-CoV-2 infection. Arch Cardiovasc Dis .
2020;
8. Castelletti S, Dagradi F, Goulene K, Danza AI, Baldi E,
Stramba-Badiale M, Schwartz PJ. A wearable remote monitoring system for
the identification of subjects with a prolonged QT interval or at risk
for drug-induced long QT syndrome. Int J Cardiol .
2018;266:89–94.
9. Garabelli P, Stavrakis S, Albert M, Koomson E, Parwani P, Chohan J,
Smith L, Albert D, Xie R, Xie Q, Reynolds D, Po S. Comparison of QT
Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart
Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients
Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol .
2016;27:827–832.
10. Malone D, Gallo T, Beck J, Clark D. Feasibility of measuring QT
intervals with a portable device. Am J Health-Syst Pharm AJHP Off
J Am Soc Health-Syst Pharm . 2017;74:1850–1851.
11. Cheung CC, Davies B, Gibbs K, Laksman ZW, Krahn AD. Multi-lead QT
Screening is Necessary for QT Measurement: Implications for Management
of Patients in the COVID-19 Era. JACC Clin Electrophysiol[Internet]. 2020 [cited 2020 Apr 21];Available from:
http://electrophysiology.onlinejacc.org/content/early/2020/04/06/j.jacep.2020.04.001
12. Vicente Jose, Johannesen Lars, Mason Jay W., Crumb William J., Pueyo
Esther, Stockbridge Norman, Strauss David G. Comprehensive T wave
Morphology Assessment in a Randomized Clinical Study of Dofetilide,
Quinidine, Ranolazine, and Verapamil. J Am Heart Assoc .
4:e001615.
13. Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, Chang
PM, Saxon LA. Wireless Smartphone ECG Enables Large-Scale Screening in
Diverse Populations. J Cardiovasc Electrophysiol .
2015;26:520–526.
14. Haverkamp HT, Fosse SO, Schuster P. Accuracy and usability of
single-lead ECG from smartphones - A clinical study. Indian Pacing
Electrophysiol J . 2019;19:145–149.